Advanced Search

 

Study ID Status Title Patient Level Data
201956 Recruiting A Long-term Access Programme for Subjects with Severe Asthma who Participated in a GSK-sponsored Mepolizumab Clinical Study
201958 Completed An open label, six-period cross-over, single and repeat dose study to determine the pharmacokinetics of fluticasone furoate and GSK961081 when administered alone, in combination, or concurrently via the ELLIPTA
201959 Completed A Phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and above Study Listed on ClinicalStudyDataRequest.com
201964 Recruiting A Phase 1 study to demonstrate the relative bioavailability of fixed dose combinations of ambrisentan and tadalafil in healthy subjects
201973 Recruiting A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ breast cancer
201974 Completed A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in healthy adults
201986 Completed PGx7611: Genetic Investigation of ALT elevations in Eltrombopag studies in ITP subjects
202007 Completed A Double-Blind, Placebo-Controlled, Dose-Escalation, First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects
202012 Completed PRJ2429: Effect of inhaled corticosteroid (ICS) particle size on asthma efficacy and safety outcomes: A systematic literature review and meta-analysis
202024 Not yet recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of Benlysta administered in Korean subjects with SLE
202026 Not yet recruiting LAMICTAL Special Drug Use Investigation(mono-therapy for Typical Absence Seizure)
202029 Recruiting ZAGALLO Capsules Drug Use Investigation
202031 Terminated A double-blind (sponsor unblind), randomized, placebo-controlled, single and repeat escalating dose study to investigate the safety, tolerability, and pharmacokinetics of CCI15106 capsules for inhalation in healthy subjects and patients with moderate chronic obstructive pulmonary disease (COPD)
202033 Recruiting Prospective Non-Interventional observational Study of use of Triumeq® and corresponding monitoring measures in clinical practice in Germany
202050 Completed PGx7607: PGx evaluation of pyrexia by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK115306 and MEK116513
202051 Completed PGX7608: PGx evaluation of efficacy of dabrafenib and trametinib by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK114267, MEK115306 and MEK116513
202055 Completed European Medicines Agency (EMA) post-authorisation safety study of influenza vaccine
202056 Completed Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: Pilot study in England
202062 Recruiting A single-centre, double-blind (sponsor open), placebo controlled two part study to evaluate the safety, tolerability and pharmacokinetics of single and repeat doses of GSK2292767 as a dry powder in healthy participants who smoke cigarettes
202063 Completed Additional subgroup analysis of onabotulinumtoxinA phase III trial in post-stroke patients with upper limb spasticity
202090 Active, Not Recruiting Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in children in Africa
202091 Completed Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in adults in Africa
202093 Completed A Phase 2a Study to Evaluate the Pharmacokinetic, Safety, Tolerability and Clinical Effect of Topically Applied Umeclidinium/GSK573719 in Subjects with Primary Axillary Hyperhidrosis
202094 Active, not recruiting An evaluation of bone mineral density in HIV-1-infected adult subjects switching from a tenofovir-containing antiretroviral therapy regimen to a dolutegravir plus rilpivirine regimen
202105 Recruiting An open label non randomized access study of trametinib for patients with advanced unresectable (stage IIIc) or distant metastatic (stage IV) BRAF V600E/K mutation positive cutaneous melanoma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.